Haoxi Health Technology Limited Class A Ordinary Shares (HAO) Fair Value & Analysis
Communication Services · US · Market cap $2.6M
Strengths
Risks
Fair value as of: Aug 17, 2026
From 10 valuation models · updated 4 days ago
Fair value updated Aug 17, 2026, revised from $0.1775 to $4.34 (+2,346.0%) since Aug 15, 2026. Share price +1,648.7% over the past month.
A solid business, screening 33% undervalued on our models.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range ($3.08 to $7.35) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 17, 2026.
How to read this chart
60‑month range $0.1316 – $1,140 · fair‑value band $3.08 – $7.35 · the $3.27 price screens below the $4.34 fair value. Dashed = 300-day average. As of Aug 17, 2026.
Analysis
Haoxi Health Technology Limited Class A Ordinary Shares (HAO) currently trades at $3.27, while our model-based Fair Value estimate is $4.34, implying the stock looks roughly 32.8% undervalued today. The Quality Score stands at 51/100 (solid quality), in the Communication Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Haoxi Health Technology Limited Class A Ordinary Shares generated revenue of $42.7M at a net margin of -6.5%. Revenue grew 41.2% year over year. It earns a return on equity of -16.0%. The balance sheet holds a net cash position of $6.6M. Fundamentals as of Aug 17, 2026
Our scenario range runs from $3.08 (bear case) to $7.35 (bull case); at $3.27, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Communication Services peers we cover trades at -13% fair-value upside, at 33%, HAO screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 10 models by family
Widest divergence: Growth Earnings ($40.53) versus Asset-Based ($6.11). Highest evidence: Growth-Adj P/E (68).
Notify me when HAO reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 57 · Market factors (momentum, volatility) 30
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, …
Full company description
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Haoxi Health Technology Limited Class A Ordinary Shares reported revenue of $32.8M in FY2025 versus $16.2M in FY2021, a compound +19.4%/yr. Reported net income was $3.9M in FY2025, compounding +99.5%/yr from FY2021.
Watch HAO: get an alert when its fair value changes →
Peer Group
Advertising Agencies · 205 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Advertising Agencies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Advertising Agencies stocks, each showing price versus our Fair Value estimate (as of Aug 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| AppLovin Corporation APP | $303.76 | $252.45 | -17% |
| Publicis Groupe S.A PUB | €99.98 | €146.36 | +46% |
| Omnicom Group OMC | $85.51 | $99.84 | +17% |
| Focus Media Information Technology Co 002027 | ¥5.29 | ¥5.71 | +8% |
| The Trade Desk, Inc TTD | $13.49 | $29.07 | +115% |
| JCDecaux SE DEC | €24.00 | €20.99 | -13% |
| Easy Click Worldwide Network Technology Co 301171 | ¥37.40 | ¥5.62 | -85% |
| Affle (India) Limited AFFLE | ₹1,711 | ₹591.41 | -65% |
| Mobvista Inc 1860 | HK$11.04 | HK$6.43 | -42% |
| Guangdong Advertising Group 002400 | ¥6.48 | ¥1.14 | -82% |
Compare Haoxi Health Technology Limited Class A Ordinary Shares with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Communication Services stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Haoxi Health Technology Limited Class A Ordinary Shares (HAO) overvalued or undervalued?
What is the fair value of HAO?
What is the quality score of HAO?
What is the revenue of Haoxi Health Technology Limited Class A Ordinary Shares (HAO)?
What is the net profit margin of HAO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Haoxi Health Technology Limited Class A Ordinary Shares and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.